PHASE-II STUDY OF SPIROGERMANIUM HYDROCHLORIDE WITH OR WITHOUT CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ADVANCED RECURRENT LYMPHOMA AND MULTIPLE-MYELOMA

被引：0
|
作者：
RIGGS, SA [1 ]
CABANILLAS, F [1 ]
ALEXANIAN, R [1 ]
LEGHA, S [1 ]
HAGEMEISTER, F [1 ]
BARLOGIE, B [1 ]
VELASQUEZ, W [1 ]
MCLAUGHLIN, P [1 ]
SALVADOR, P [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1985年 / 26卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [41] PHASE-II TRIAL OF PIPERAZINEDIONE IN HODGKINS-DISEASE, NON-HODGKINS LYMPHOMA, AND MULTIPLE-MYELOMA - SOUTHWEST ONCOLOGY GROUP STUDY
    JONES, SE
    TUCKER, WG
    HAUT, A
    TRANUM, BL
    VAUGHN, C
    CHASE, EM
    DURIE, BGM
    CANCER TREATMENT REPORTS, 1977, 61 (09): : 1617 - 1621
  • [42] INTERMITTENT SEQUENTIAL HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE (IS-HAM) FOR REFRACTORY ACUTE LEUKEMIAS - A PHARMACOLOGICALLY DESIGNED PHASE-II STUDY
    SCHLEYER, E
    BIRKFELLNER, T
    WORMANN, B
    BUCHNER, T
    HIDDEMANN, W
    BLOOD, 1993, 82 (10) : A256 - A256
  • [43] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND LOW-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES - A PHASE-II STUDY
    HOFFKEN, K
    OVERKAMP, F
    STIRBU, J
    GROTHEY, A
    FLASSHOVE, M
    HOELZER, D
    GANSER, A
    ONKOLOGIE, 1990, 13 (01): : 33 - &
  • [44] PHASE-II EVALUATION OF ACLARUBICIN IN REFRACTORY MULTIPLE-MYELOMA - A SOUTHEASTERN-CANCER-STUDY-GROUP TRIAL
    GOCKERMAN, JP
    SILBERMAN, H
    BARTOLUCCI, AA
    CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 773 - 774
  • [45] PHASE-II EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY OF SPIROGERMANIUM IN PREVIOUSLY TREATED LYMPHOMA
    BOROS, L
    TSIATIS, AA
    NEIMAN, RS
    MANN, RB
    GLICK, JH
    CANCER TREATMENT REPORTS, 1986, 70 (07): : 917 - 918
  • [46] PHASE-II EVALUATION OF ETOPOSIDE IN REFRACTORY MULTIPLE-MYELOMA - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
    GOCKERMAN, JP
    BARTOLUCCI, AA
    NELSON, MO
    SILBERMAN, H
    VELEZGARCIA, E
    STEIN, R
    CANCER TREATMENT REPORTS, 1986, 70 (06): : 801 - 802
  • [47] PHASE-II TRIAL OF PYRAZOFURIN IN PATIENTS WITH MULTIPLE-MYELOMA REFRACTORY TO STANDARD CYTOTOXIC THERAPY
    LAKELEWIN, D
    MYERS, J
    LEE, BJ
    YOUNG, CW
    CANCER TREATMENT REPORTS, 1979, 63 (08): : 1403 - 1404
  • [48] MENOGARIL IN THE TREATMENT OF RELAPSED MULTIPLE-MYELOMA - A PHASE-II TRIAL OF THE CANCER CENTER OF WAKE-FOREST-UNIVERSITY
    CRUZ, JM
    CASE, LD
    DALTON, HB
    RAMSEUR, WL
    RICHARDS, F
    JACKSON, DV
    MUSS, HB
    ZEKAN, PJ
    BRODKIN, RA
    BROWN, RC
    HERRING, WB
    LUSK, JA
    OROURKE, MA
    REDDY, SM
    CAPIZZI, RL
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (01) : 35 - 37
  • [49] PHASE-II STUDY WITH CIS-DIAMMINEDICHLOROPLATINUM(II) IN THE TREATMENT OF ADVANCED MALIGNANT-LYMPHOMA
    CAVALLI, F
    JUNGI, WF
    SONNTAG, RW
    NISSEN, NI
    HOLLAND, JH
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1980, 110 (27-2) : 1067 - 1070
  • [50] PHASE-I-II STUDY OF EPIRUBICIN IN MULTIPLE-MYELOMA
    CASE, DC
    ERVIN, TJ
    GAMS, R
    SONNEBORN, H
    PAUL, S
    OLDHAM, FB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 213 - 213
12345